Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
新型 HDAC 抑制剂 MAKV-8 和伊马替尼通过抑制 BCR-ABL/MYC 信号传导协同杀死慢性粒细胞白血病细胞：对伊马替尼耐药性和干细胞的影响
期刊:Clinical Epigenetics
影响因子:
doi:10.1186/s13148-020-00839-z
Manon Lernoux, Michael Schnekenburger, Hélène Losson, Koen Vermeulen, Hyunggu Hahn, Déborah Gérard, Jin-Young Lee, Aloran Mazumder, Muneer Ahamed, Christo Christov, Dong-Wook Kim, Mario Dicato, Guy Bormans, Byung Woo Han, Marc Diederich
信号转导
发育与干细胞
肿瘤
白血病
干细胞
粒细胞
WB
CASP3
